 |
Treatment Access Grants
Grants listed by date, with most recent appearing first. Click a grant title for detailed information, including a summary and publications.
| Reducing or Expanding Substance Use Disorder Treatment Programs: Evaluating Impact from the Health Care Decision-Maker's Perspective, Keith Humphreys, Ph.D. |
| Increasing Access to Substance Abuse Treatment: Resolving the Not in My Back Yard Phenomenon Regarding Substance Abuse Treatment Centers, Susan Boyd, M.D. |
| Evaluation of Pharmacy-Based Drug Treatment Linkages through the New York State Expanded Syringe Access Demonstration Program (ESAP), Crystal Fuller, Ph.D. |
| Service Delivery and Use of Evidence-Based Treatment Practice in Adolescent Substance Abuse Treatment Settings, Hannah Knudsen, Ph.D. |
| Understanding the Impacts of Funding Volatility on Treatment Services, Patricia Ebener, |
| Improving Treatment for Medicaid Beneficiaries with Co-Occurring Disorders, Robin Clark, Ph.D. |
| Pharmacists' Knowledge and the Drug Addiction Treatment Act, Tony Tommasello, Ph.D. |
| Supplement to Implementation and Impact of California's Proposition 36: Implications for the Future, Nell Griffith Forge, Ph.D., M.P.H. |
| Office-Based Buprenorphine in Washington State, Joseph Merrill, M.D., M.P.H. |
| Public Financing and Treatment for Dual Disorders: A Case Study, Robin Clark, Ph.D. |
| Substance Abuse Treatment for Pregnant Women Under Managed Care, Janet Mitchell, Ph.D. |
| Impact of Managed Care Contracting Arrangements on Access to Substance Abuse Services, Janet Mitchell, Ph.D. |
| Supplement to: Elimination of Drug and Alcohol Abuse as an Eligibility Category for SSI, Shanthi Kappagoda, M.S. |
| The Impact of Welfare Reform on Mothers Convicted of a Drug Offense, Carol Boyd, M.S.N., Ph.D., R.N. |
| Pathways to Substance Abuse Treatment for Adolescents in an HMO: Implications for Policy, Constance Weisner, Dr.P.H., M.S.W. |
| Increasing Substance Abuse Screening and Referral Rates in an Independent Practice Association Managed Health Care Organization, Neal Dawson, M.D. |
| Welfare Reform and Substance Abuse Policy Changes: Reducing the Harm to Parents, Heroin Addicts, and Disabled Persons, Richard Speiglman, D.Crim. |
| Identifying Best Practices among Managed Care Plans that Provide Substance Abuse Treatment Services to Medicaid Recipients with Disabilities, Sara Bachman, Ph.D. |
| Methadone Maintenance in Primary Care, Joseph Merrill, M.D., M.P.H. |
| The Impact of Treatment on Demand on Injection Drug Users in the SF Bay Area, Brian Edlin, M.D. |
| Developing a Foundation for Outcome Based Purchasing of Addictions Treatment, Norman Hoffmann, Ph.D. |
| Effects of the Elimination of SSI Drug Addiction and Alcoholism Eligibility: Phase 2, Richard Speiglman, D.Crim. |
| Impact of Terminating DA&A SSI/SSDI Benefits, Paul Goldstein, Ph.D. |
| An Ethical and Legal Analysis of State-compelled Loss of Liberty as an Intervention to Reduce the Harm of Perinatal Substance Abuse and Addiction, Mary Faith Marshall, Ph.D. |
| Effects of the Elimination of SSI Drug Addiction and Alcoholism: Phase I, Richard Speiglman, D.Crim. |
| Perinatal Substance Use Treatment and Related Services in a Managed Care Environment, Mary Haack, Ph.D. |
| Federal and State Level Policies and Women: Impact on Services for Alcohol, Tobacco, and Other Drugs, Beth Reed, Ph.D. |
|
|
